Joy Yang Ge
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
- Oncology 29
- Cancer Immunotherapy and Biomarkers 24
- Cancer Diagnosis and Treatment 8
- CAR-T cell therapy research 3
- Lung Cancer Research Studies 3
- Peptidase Inhibition and Analysis 3
-
- Head and Neck Cancer Studies 14
- Co-authors
- Robert Bachman (4 shared papers)David Michelson (2 shared papers)Christopher Assaid (2 shared papers)Sheena K. Aurora (1 shared paper)Tiffini Voss (1 shared paper)David W. Dodick (1 shared paper)Richard B. Lipton (1 shared paper)Leena Gandhi (6 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Annals of Oncology (9 papers)Cancer Research (3 papers)Oral Oncology (2 papers)Cephalalgia (1 paper)
- Partner nations
- United StatesCanadaTaiwan
In The Last Decade
Joy Yang Ge
33 papers receiving 720 citations
Joy Yang Ge's Hit Papers
Peers
Comparison fields: 5 of 52
- Otorhinolaryngology 135
- Oncology 377
- Psychiatry and Mental health 189
- Immunology 122
- Pathology and Forensic Medicine 95
Countries citing papers authored by Joy Yang Ge
This map shows the geographic impact of Joy Yang Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Yang Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Yang Ge more than expected).
Fields of papers citing papers by Joy Yang Ge
This network shows the impact of papers produced by Joy Yang Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Yang Ge. The network helps show where Joy Yang Ge may publish in the future.
Co-authors
The 25 scholars most cited alongside Joy Yang Ge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 192 | |
| 2 | Pembrolizumab alone or with chemotherapy for recurrent/metastatic head and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by Programmed Death Ligand-1 combined positive score Hit paper breakdown → | 2022 | 115 |
| 3 | 2016 | 74 | |
| 4 | 2015 | 61 | |
| 5 | 2016 | 40 | |
| 6 | 2019 | 33 | |
| 7 | 2016 | 31 | |
| 8 | 2015 | 31 | |
| 9 | 2021 | 26 | |
| 10 | 2017 | 15 | |
| 11 | 2018 | 14 | |
| 12 | 2020 | 12 | |
| 13 | 2023 | 9 | |
| 14 | 2017 | 8 | |
| 15 | 2020 | 8 | |
| 16 | 2019 | 8 | |
| 17 | 2024 | 8 | |
| 18 | 2015 | 6 | |
| 19 | 2020 | 6 | |
| 20 | 2019 | 5 |
About Joy Yang Ge
Joy Yang Ge is a scholar working on Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 36 papers that have together received 730 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (24 papers), Head and Neck Cancer Studies (14 papers), Cancer Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (4 papers), CAR-T cell therapy research (3 papers), Lung Cancer Research Studies (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Otorhinolaryngology (135 citations), Oncology (377 citations), Psychiatry and Mental health (189 citations), Immunology (122 citations) and Pathology and Forensic Medicine (95 citations). Joy Yang Ge has collaborated with scholars based in United States, Canada and Taiwan. Frequent co-authors include Robert Bachman, David Michelson, Christopher Assaid, Sheena K. Aurora, Tiffini Voss, David W. Dodick, Richard B. Lipton, Leena Gandhi, James Stevenson and Matthew A. Gubens. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Oral Oncology and Cephalalgia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.